Assyro AI

Orange Book product · Brand (NDA)

LOCAMETZ

GALLIUM GA-68 GOZETOTIDE

Brand (NDA)NDA 215841RX NOVARTIS

At a glance

Mar 23, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 23, 2022

    4 yr 4 mo ago

  2. Today

  3. Patent 11369590 expires

    Listed drug substance patent expiration.

    Aug 15, 2028

    in 2 yr 2 mo

  4. Patent 12109277 expires

    Listed method-of-use patent (U-4002) expiration.

    Mar 09, 2036

    in 9 yr 10 mo

Pharmaceutical detail

Active ingredient

GALLIUM GA-68 GOZETOTIDE

Strength

N/A

Dosage form

POWDER

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 215841

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11369590Aug 15, 2028in 2 yr 2 mo
SubstanceProductU-3400
12109277Mar 09, 2036in 9 yr 10 mo
U-4002
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.